Phase II Study of Oral Panobinostat in Adult Participants With Relapsed/Refractory Classical Hodgkin's Lymphoma

PHASE2CompletedINTERVENTIONAL
Enrollment

129

Participants

Timeline

Start Date

September 16, 2008

Primary Completion Date

August 12, 2013

Study Completion Date

August 12, 2013

Conditions
Classical Hodgkin's Lymphoma
Interventions
DRUG

Panobinostat

Panobinostat hard gelatin capsules.

Trial Locations (46)

1000

Novartis Investigative Site, Brussels

3000

Novartis Investigative Site, Leuven

3144

Novartis Investigative Site, Malvern

4029

Novartis Investigative Site, Herston

6000

Novartis Investigative Site, Charleroi

10126

Novartis Investigative Site, Torino

13273

Novartis Investigative Site, Marseille

20089

Novartis Investigative Site, Rozzano

20162

Novartis Investigative Site, Milan

21034

Novartis Investigative Site, Dijon

21201

VA Maryland Health Care Dept.of GreenbaumCancerCent(5), Baltimore

26506

West Virginia University/ Mary Babb Randolph Cancer Center, Morgantown

28006

Novartis Investigative Site, Madrid

30322

Emory University School of Medicine/Winship Cancer Institute Dept. of Hematology (2), Atlanta

30912

Georgia Regents University Cancer Clinical Research Unit, Augusta

33100

Novartis Investigative Site, Udine

35019

Novartis Investigative Site, Rennes

37075

Novartis Investigative Site, Göttingen

40138

Novartis Investigative Site, Bologna

48201

Karmanos Cancer Institute Div.of Hematology/Oncology, Detroit

50924

Novartis Investigative Site, Cologne

52621

Novartis Investigative Site, Ramat Gan

55905

Mayo Clinic - Rochester Hematology, Rochester

60612

Rush University Medical Center Divisionof Hem/Onc Research(2), Chicago

68000

Novartis Investigative Site, Kuala Selangor

69373

Novartis Investigative Site, Lyon

77030

The Methodist Hospital Cell & Gene Therapy Clinic, Houston

78229

Cancer Therapy & Research Center / UT Health Science Center InstituteForDrugDevelopment(5), San Antonio

84101

Novartis Investigative Site, Beersheba

91120

Novartis Investigative Site, Jerusalem

94805

Novartis Investigative Site, Villejuif

169608

Novartis Investigative Site, Singapore

91010-3000

City of Hope National Medical Center Dept.ofCityofHopeMedicalCtr(2), Duarte

02115

Dana Farber Cancer Institute Hematology / Oncology, Boston

19104-4283

University of Pennsylvania Medical Center Dept of UPenn Med Ctr (3), Philadelphia

77030-4009

University of Texas/MD Anderson Cancer Center Dept.ofMDAndersonCancerCtr(3), Houston

21941-913

Novartis Investigative Site, Rio de Janeiro

13083-970

Novartis Investigative Site, Campinas

01224-000

Novartis Investigative Site, São Paulo

05403-000

Novartis Investigative Site, São Paulo

59 037

Novartis Investigative Site, Lille

01307

Novartis Investigative Site, Dresden

Unknown

Novartis Investigative Site, Auckland

Novartis Investigative Site, Southampton

08025

Novartis Investigative Site, Barcelona

M20 4BX

Novartis Investigative Site, Withington

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY